Minorities make up about 40% of the U.S. population yet on average, fewer than 5% of participants in clinical trials are from minority groups such as African Americans, Latinos, Asians and others. This problem is compounded because these minority groups are disproportionately impacted by medical conditions including cardiovascular disease, hypertension, and diabetes—e.g. African Americans are 80% more likely to have diabetes and 30% more likely to die from heart disease than whites. An entrepreneur saw an opportunity fill an important need and recently launched Drugviu, an online platform encouraging minority populations to not only review their experiences taking specific medications but also to potentially participate in a more meaningful way in the health system including clinical research. The venture was launched out of the MATTER health care startup incubator in the Merchandise Mart in Chicago.
Reported on recently in the Chicago Sun-Times by Ryan Smith, TrialSite News breaks down this new venture.
What is Venture?
Drugviu. Founded by Kwaku Owusu and Melanie Igwe both appeared to have spent a few years in health care finance consulting with what appears to be a strug...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).